A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.
Via WIRED
But that hasn’t stopped the push for gene-edited human embryos, with biotech entrepreneur Cathy Tie arguing that doing so isn’t just urgent—it’s a “moral imperative.”
Tie is the 30-year-old founder of Origin Genomics, a company that launched in March with plans to bring gene-edited embryos to IVF clinics. In a new commentary published in the journal Trends in Genetics, she argues for public funding and new regulatory pathways to advance gene-edited babies and eventually move into clinical use.
But questions…
Courtesy
This story was originally published by WIRED. All rights belong to the original publisher.
Read the original on wired.com ↗